Random important alterations in HIV-1 viral quasispecies after antiviral treatment

Antiviral Therapy

Volumn 1, Issue 4, 1996, Pages 225-236

  Sánchez Palomino, Sonsoles ^a,c   Olivares, Isabel ^a   Yuste, Eloisa ^a   Richman, Douglas D ^b   López Galíndez, Cecilio ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ZIDOVUDINE;

ARTICLE; DRUG EFFECT; GENETICS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; STRUCTURAL GENE; VIRUS GENOME;

ANTI-HIV AGENTS; BASE SEQUENCE; GENES, POL; GENOME, VIRAL; HELA CELLS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; ZIDOVUDINE;

EID: 0030307888     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Eigen M. Self-organization of matter and the evolution of biological macromolecules. Naturwissenschaften 1971; 58:465-523.
2. Buonagurio DA, Nakada S, Parvin PA, Krystal M, Palese P & Fitch WM. Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene. Science 1986; 232:980-982.
3. Scarlati G, Leitner T, Hodara V, Halapi E, Rossi P, Albert J & Fenyo EM. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1. AIDS 1993; 7(Suppl. 2):S45-S48.
4. Wolinsky SM, Wike CM, Korber BTM, Hutto C, Parks WP, Rosemblum LL, Kunstman KJ, Furtado MR & Muñoz JL. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992; 255:1134-1137.
5. Duarte EA, Novella IS, Weaver SC, Domingo E, Wain-Hobson S, Clarke DK, Moya A, Elena SF, de la Torre JC & Holland J. RNA virus quasispecies: significance for viral disease and epidemiology. Infectious Agents and Disease 1994; 3:201-214.
6. Richman DD. Drug resistance in relation to pathogenesis. AIDS 1995; 9(Suppl. A):S49-S53.
7. Cheynier R, Henrichwark S, Hadida F, Pelletier E, Okesenhendler E, Autran B & Wain-Hobson S. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 1994; 78:373-387.
8. Wain-Hobson, S. The fastest genome evolution ever described: HIV variation in situ. Current Opinions in Genetics and Development 1993; 3:878-883.
9. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM & Markowit M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-126.
10. Richman DD, Havlir D, Corbeil J, Looney D, Ignacio C, Spector SA, Sullivan J, Cheeseman S, Barringer K, Pauletti D, Shih C-K, Myers M & Griffin J. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. Journal of Virology 1994; 68:1660-1666.
11. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifso JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS & Shaw GM. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373:117-122.
12. Larder BA, Darby G & Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989; 243:1731-1734.
13. Larder BA & Kemp S. Multiple mutations in high level resistance. Science 1989; 246:1155-1158.
14. Mayers DL, McCutchan F, Sanders-Buell EE, Merritt L, Dilworth S, Fowler AK, Marks CA, Ruiz NM, Richman DD, Roberts CR & Burke DS. Characterization of HIV-1 isolates arising after prolonged zidovudine therapy. Journal of Acquired Immune Deficiency Syndromes 1992; 5:749-759.
15. Winter E, Yamamoto F, Almoguera C & Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1985; 327:298-303.
16. López-Galíndez C, Rojas JM, Najera R, Richman DD & Perucho M. Characterization of genetic variation and 3′-azido-3′-deoxythymidine-resistance mutations of human immunodeficiency virus by the RNase A mismatch cleavage method. Proceedings of the National Academy of Sciences, USA 1991; 88:4280-4284.
17. Harada S, Koyanagi Y & Yamamoto N. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 1985; 229:563-566.
18. Sánchez-Palomino S, Rojas JM, Martínez MA, Fenyo EM, Najera R, Domingo D & López-Galíndez C. Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture. Journal of Virology 1993; 67:2938-2943.
19. Nájera I, Richman DD, Olivares I, Rojas JM, Peinado MA, Perucho M, Nájera R & López-Galíndez C. Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates. AIDS Research & Human Retroviruses 1994; 10:1479-1488.
20. Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rafalski ER, Whichorn E, Baumeisteir K, Ivanoff L, Petteway SRJ, Pearson ML, Lautenbergen JA, Papas TS, Chrayeb J, Chang NT, Gallo RC & Wong-Stall F. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985; 313:277-284.
21. Perucho M. Detection of single-base substitutions with the RNase A mismatch cleavage method. Strategies 1989; 2:37-41.
22. Cochrane AW, Chen CH & Rosen C. Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proceedings of the National Academy of Sciences, USA 1990; 87:1198-1202.
23. Domingo E, Martínez-Salas E, Sobrino F, de la Torre JC, Portela A, Ortin J, López-Galíndez C, Pérez-Breña P, Villanueva N, Nájera R, VandePol S, Steinhauer D, DePolo N & Holland JJ. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance - a review. Gene 1985; 40:1-8.